FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to a method for determining the functional activity of the rat complement system. A method for determining the functional activity of the rat complement system includes carrying out a lysis reaction of human erythrocytes of group A of the AB0 system [E(A)], sensitized with anti-A monoclonal IgM antibodies [E(A)mAb], and serum under conditions of veronal saline buffer (VBS2+), incubation of the obtained sample, then evaluate the reaction of complement-dependent lysis of E(A) mAb.
EFFECT: above method improves the accuracy of the method for studying the functional activity of the classical pathway of the complement system, as well as simplifies the registration of the results of the analysis of the functional activity of the classical pathway of the complement system in routine studies and adapts the method for screening studies in clinical diagnostic laboratories.
1 cl, 5 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING SEVERITY OF SYSTEMIC INFLAMMATORY RESPONSE IN HUMAN BODY IN DISEASES | 2022 |
|
RU2808416C1 |
METHOD OF DETERMINING THE ACTIVITY OF THE CLASSICAL AND ALTERNATIVE PATHWAYS OF THE MOUSE COMPLEMENT SYSTEM | 2022 |
|
RU2800363C1 |
METHOD FOR DETERMINING COMPLEMENT-ACTIVATING FUNCTION OF SARS-CoV-2 ANTIBODIES FOR PREDICTING SEVERITY OF COVID-19 | 2023 |
|
RU2818351C1 |
METHOD FOR DETERMINING THE INHIBITORY POTENTIAL OF BLOOD FOR PREDICTING UNCONTROLLED ACTIVATION OF COMPLEMENT SYSTEM IN COVID-19 | 2023 |
|
RU2814496C1 |
METHOD FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE HUMAN COMPLEMENT SYSTEM FOR PREDICTING THE SEVERITY OF THE COURSE OF A SYSTEMIC INFLAMMATORY REACTION | 2021 |
|
RU2756764C1 |
SCREENING TEST FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE CLASSIC COMPLEMENT PATHWAY | 2018 |
|
RU2704121C1 |
METHOD OF DETERMINING C3-CONVERTASE STABILISATION OF CLASSICAL WAY OF HUMAN COMPLEMENT ACTIVATION | 2013 |
|
RU2549468C2 |
METHOD FOR DETERMINING FUNCTIONAL ACTIVITY OF IONISED CALCIUM IN HUMAN BLOOD SERUM | 2013 |
|
RU2526824C1 |
METHOD FOR RAPID ANALYSIS OF CHOLESTEROL IN IMMUNE COMPLEXES | 2013 |
|
RU2538685C1 |
METHOD FOR ASSAY OF IMMUNE STATUS DISORDER | 2002 |
|
RU2247381C2 |
Authors
Dates
2022-12-19—Published
2022-04-05—Filed